Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 22, 2010
Methemoglobinemia induced by 1,2-dichloro-4-nitrobenzene in mice with a disrupted glutathione S-transferase Mu 1 geneShingo Arakawa, Takanori Maejima, Naoki Kiyosawa, et al.
Molecular Cancer Therapeutics|February 12, 2022
DS-7300a, a DNA Topoisomerase I Inhibitor, DXd-Based Antibody-Drug Conjugate Targeting B7-H3, Exerts Potent Antitumor Activities in Preclinical ModelsMichiko Yamato, Jun Hasegawa, Takanori Maejima, et al.
Toxicologic Pathology|April 17, 2003
Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic miceMasaya Takaoka, Shinya Sehata, Takanori Maejima, et al.
Cancers|June 19, 2024
The Comprehensive Characterization of B7-H3 Expression in the Tumor Microenvironment of Lung Squamous Cell Carcinoma: A Retrospective StudyAyaka Asakawa, Ryoto Yoshimoto, Maki Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2024
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft ModelsFunda Meric-Bernstam, Erkan Yuca, Kurt W Evans, et al.
Molecular Cancer Therapeutics|August 20, 2021
Datopotamab Deruxtecan, a Novel TROP2-directed Antibody-drug Conjugate, Demonstrates Potent Antitumor Activity by Efficient Drug Delivery to Tumor CellsDaisuke Okajima, Satoru Yasuda, Takanori Maejima, et al.
Pageof 2